Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200070 · ClinicalTrials.gov registry record · Phase 3
Neurostimulation to Treat Refractory Angina Pectoris Pain
A Phase 3 study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- Phase 3
- Development phase
- 228
- Enrollment target
NCT00200070 is a Phase 3 study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 228 participants.
The verdict
NCT00200070, a Phase 3 study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 228 participants
- Enrollment target
Study Summary
The therapy under investigation involves an implanted Medtronic neurostimulation system to relieve symptoms of angina pectoris pain. Electrical impulses are applied to targeted areas of the spinal cord through an implanted lead (a flexible insulated wire) that is powered by an implanted battery.
Interventions
- DEVICE Spinal Cord Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2002-12 |
| Est. Completion | 2007-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200070
The ClinicalTrials.gov registry entry for NCT00200070 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Stimulation is the first listed.
NCT00200070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200070 about?
NCT00200070 is a clinical study titled "Neurostimulation to Treat Refractory Angina Pectoris Pain". The therapy under investigation involves an implanted Medtronic neurostimulation system to relieve symptoms of angina pectoris pain. Electrical impulses are applied to targeted areas of the spinal cord through an implanted lead (a flexible insulated wire) that is powered by an implanted battery.
What is the current status of trial NCT00200070?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 228 participants. The study started on 2002-12. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00200070?
The interventions under investigation include: Spinal Cord Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00200070?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.